Suppr超能文献

New Insulins, Biosimilars, and Insulin Therapy.

作者信息

Danne Thomas, Heinemann Lutz, Bolinder Jan

机构信息

Diabetes Centre for Children and Adolescents, Kinder- und Jugendkrankenhaus (Auf der Bult), Hannover, Germany.

Science Consulting in Diabetes GmbH, Neuss, Germany.

出版信息

Diabetes Technol Ther. 2020 Feb;22(S1):S32-S46. doi: 10.1089/dia.2020.2503.

Abstract
摘要

相似文献

1
New Insulins, Biosimilars, and Insulin Therapy.新型胰岛素、生物类似药与胰岛素治疗
Diabetes Technol Ther. 2020 Feb;22(S1):S32-S46. doi: 10.1089/dia.2020.2503.
2
New Insulins, Biosimilars, and Insulin Therapy.新型胰岛素、生物类似药与胰岛素治疗
Diabetes Technol Ther. 2018 Feb;20(S1):S55-S70. doi: 10.1089/dia.2018.2505.
3
New Insulins, Biosimilars, and Insulin Therapy.新型胰岛素、生物类似药与胰岛素治疗
Diabetes Technol Ther. 2016 Feb;18 Suppl 1:S43-55. doi: 10.1089/dia.2016.2505.
5
New Insulins, Biosimilars, and Insulin Therapy.新型胰岛素、生物类似药与胰岛素治疗
Diabetes Technol Ther. 2017 Feb;19(S1):S42-S58. doi: 10.1089/dia.2017.2505.
6
Introduction of biosimilar insulins in Europe.欧洲的生物类似胰岛素介绍。
Diabet Med. 2017 Oct;34(10):1340-1353. doi: 10.1111/dme.13400. Epub 2017 Jul 16.
7
Biosimilar Insulin and Costs: What Can We Expect?生物类似物胰岛素与成本:我们能期待什么?
J Diabetes Sci Technol. 2015 Sep 8;10(2):457-62. doi: 10.1177/1932296815605337.
8
New Insulins, Biosimilars, and Insulin Therapy.新型胰岛素、生物类似药与胰岛素治疗
Diabetes Technol Ther. 2021 Jun;23(S2):S46-S68. doi: 10.1089/dia.2021.2504.
9
New Insulins, Biosimilars, and Insulin Therapy.新型胰岛素、生物类似药与胰岛素治疗
Diabetes Technol Ther. 2023 Feb;25(S1):S44-S69. doi: 10.1089/dia.2023.2504.
10
New Insulins, Biosimilars, and Insulin Therapy.新型胰岛素、生物类似药与胰岛素治疗
Diabetes Technol Ther. 2019 Feb;21(S1):S57-S78. doi: 10.1089/dia.2019.2505.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验